Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Alba Therapeutics closes $30mm Series A round

Executive Summary

Alba Therapeutics (develops drugs and drug delivery adjuvants based on the zonulin pathway) raised $30mm in its Series A financing led by SV Life Sciences and Alta Partners. Other new investors HealthCap, Red Abbey Venture Partners, and the Maryland Venture Fund were joined by returning backers Esperance BioVentures, Astellas Ventures, Maryland TEDCO, and Townsend Capital.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies